DiaMedica Therapeutics (DMAC.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec20

Craig-Hallum Analyst Reiterates Buy Rating on DiaMedica

05:51

Nov14

Lake Street Analyst Maintains Buy Rating for DiaMedica Therapeutics, Sets Price Target at $14.00

14:37

Nov13

DiaMedica Therapeutics released FY2025 9 Months earnings on November 12 After-Market (EST), actual revenue USD 0, actual EPS USD -0.3591

00:00

DiaMedica Therapeutics released FY2025 Q3 earnings on November 12 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1736 (forecast USD -0.16)

00:00

Nov5

DiaMedica Therapeutics to Release FY2025 Q3 Earnings on November 12 After-Market EST, Forecast EPS -0.16 USD

00:05

Aug12

DiaMedica Therapeutics released FY2025 Semi-Annual earnings on August 12 After-Market EST, actual revenue USD 0, actual EPS USD -0.3591

23:00

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.62 M, EPS -0.1736

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.699 M, EPS -0.1792

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -7.707 M, EPS -0.1798

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change